1-3 of 3
Charan Vegivinti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Overall response rates and progression free survival rates of bispecific antibodies vs CAR-T in the treatment of extramedullary disease and high-risk cytogenetics in relapsed multiple myeloma: A systematic review and meta-analysis

Free
Charan Vegivinti, Nikhil Vojjala, Jaison Lawrence Alexander Santhi, Lawrence Liu, Praneeth Reddy Keesari, Rahul Thakur, Ujwala Koduru, Aravind Kunadi, Krishna Chaithanya Madhavarapu, Ananta Ghimire, Murali Mohan Gopireddy, Murali Janakiram
Journal: Blood
Blood (2025) 146 (Supplement 1): 7599.
https://doi.org/10.1182/blood-2025-7599
Published: 2025
Journal Articles

Efficacy of CAR-T cell therapy in chronic lymphocytic leukemia: A meta-analysis

Free
Jaison Lawrence Alexander Santhi, Charan Vegivinti, Hassan Ali, Sai Abhishek Narra, Sivaguha Yadunath Prabhakaran, Sohiel Deshpande, Kirshna Desai, Sataya Durugu, Berkha Rani, Aftab Ahmed, Alexandra Boc, Elizaveta Bodrova, Reema Sara Varghese, Abul Hasan Shadali Abdul Khader, Shammas Bajwa, Fredy Abboud, Amanda McMillen, Benjamin Gabrieliants, Sungwook Kim, Rajesh Thirumaran
Journal: Blood
Blood (2025) 146 (Supplement 1): 2740.
https://doi.org/10.1182/blood-2025-2740
Published: 2025
Journal Articles

Real-world comparison of thrombotic events in patients with Myelodysplastic Syndromes treated with luspatercept versus erythropoietin-stimulating agents using trinetx database

Free
Nikhil Vojjala, Syed Fahad Gillani, Raj Shah, Himil Mahadevia, Charan Vegivinti, Shubham Agrawal, Vijendra Singh
Journal: Blood
Blood (2025) 146 (Supplement 1): 22.
https://doi.org/10.1182/blood-2025-22
Published: 2025